Payers and providers now expect RWE to complement trial efficacy by demonstrating effectiveness, utilization impact, and ROI ...
Claude Code is expected to standardize and accelerate software and AI development while improving access to data and ...
In this week's Pharma Pulse, the Trump administration expands TrumpRx to over 600 generics, the Supreme Court clears the way for long-term Medicare drug price negotiations, Eli Lilly moves deeper into ...
High copays, restrictive networks, and travel distances leave many rural Americans facing steep barriers to prescription access. For millions of Americans living in rural communities, access to ...
Execution infrastructure converts early commercial and supply signals into owned, cross-functional workflows with decision logic and closure tracking, preventing insights from stalling in dashboards.
Formulary positioning and benefit design frequently determine utilization, as weak placement or reimbursement dynamics can ...
TrumpRx’s sevenfold formulary expansion positions a government-backed portal as a high-volume generics price aggregator rather than a dispensing pharmacy. Tariff exemptions tied to three-year ...
Integrated direct-to-patient models use AI-enabled eBenefits/eVerification plus real-time claims adjudication to surface ...
Supreme Court inaction leaves intact lower-court rulings rejecting takings and compelled-speech theories against “fair price” designations in Medicare price negotiation. Courts emphasized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results